Literature DB >> 8738914

Gene conversion and homologous recombination in murine B cells.

E Selsing1, B Xu, D Sigurdardottir.   

Abstract

Gene conversion has been found to be important in the diversification of antibody genes in chickens and in rabbits. In other species, however, it is not clear whether gene conversion plays any role in antibody diversity. Analysis of an H-chain antibody gene construct that was designed to optimize the detection of gene conversion events in transgenic mice has shown that sequence transfers that resemble gene conversion events can occur in murine B cells and are associated with somatic hypermutation. This raises the possibility that an error-prone gene conversion mechanism might play a role in murine somatic hypermutation.

Entities:  

Mesh:

Year:  1996        PMID: 8738914     DOI: 10.1006/smim.1996.0019

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  5 in total

Review 1.  The reverse transcriptase model of somatic hypermutation.

Authors:  E J Steele; R V Blanden
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-01-29       Impact factor: 6.237

2.  Cis-acting regulatory sequences promote high-frequency gene conversion between repeated sequences in mammalian cells.

Authors:  Steven J Raynard; Mark D Baker
Journal:  Nucleic Acids Res       Date:  2004-11-04       Impact factor: 16.971

3.  Gene conversion in human rearranged immunoglobulin genes.

Authors:  John M Darlow; David I Stott
Journal:  Immunogenetics       Date:  2006-05-17       Impact factor: 2.846

4.  Gene Conversion-Like Events in the Diversification of Human Rearranged IGHV3-23*01 Gene Sequences.

Authors:  Bhargavi Duvvuri; Gillian E Wu
Journal:  Front Immunol       Date:  2012-06-15       Impact factor: 7.561

5.  DNA-dependent protein kinase activity is not required for immunoglobulin class switching.

Authors:  Gayle C Bosma; Jiyoon Kim; Teresa Urich; Donna M Fath; Maria G Cotticelli; Norman R Ruetsch; Marko Z Radic; Melvin J Bosma
Journal:  J Exp Med       Date:  2002-12-02       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.